These findings highlight TRPM6 as a critical mediator of Mg2+ function and a promising candidate for prognostic stratification and therapeutic targeting in CRC, laying the groundwork for future studies on its regulatory mechanisms in tumor progression and the development of Mg2+-based therapeutic strategies. Here, TRPM6 is linked to neoplasm.